Article
Teva recalls one lot of leukemia med after finding particulates in vial
Rating:
0.0
Views:
57
Likes:
1
Library:
1
Particulate contamination of injectable drugs isn't just a hindrance for manufacturers and customers: it can pose serious health risks, too. | Teva Pharmaceutical is pulling one lot of its injectable leukemia med IDArubicin hydrochloride in the U.S. after an internal inspection uncovered silica and iron oxide particulate matter in a lone drug vial. The defect hasn't turned up in any other vials, and Teva hadn't received any side effect reports as of Tuesday, the company said.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value